BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 12614563)

  • 1. Highly efficient and tumor-restricted gene transfer to malignant gliomas by replication-competent retroviral vectors.
    Wang WJ; Tai CK; Kasahara N; Chen TC
    Hum Gene Ther; 2003 Jan; 14(2):117-27. PubMed ID: 12614563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-shot, multicycle suicide gene therapy by replication-competent retrovirus vectors achieves long-term survival benefit in experimental glioma.
    Tai CK; Wang WJ; Chen TC; Kasahara N
    Mol Ther; 2005 Nov; 12(5):842-51. PubMed ID: 16257382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highly efficient gene delivery for bladder cancers by intravesically administered replication-competent retroviral vectors.
    Kikuchi E; Menendez S; Ozu C; Ohori M; Cordon-Cardo C; Logg CR; Kasahara N; Bochner BH
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4511-8. PubMed ID: 17671137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of replication-competent retroviral vectors in an immunocompetent intracranial glioma model.
    Wang W; Tai CK; Kershaw AD; Solly SK; Klatzmann D; Kasahara N; Chen TC
    Neurosurg Focus; 2006 Apr; 20(4):E25. PubMed ID: 16709031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
    Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K
    J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats.
    Ram Z; Culver KW; Walbridge S; Blaese RM; Oldfield EH
    Cancer Res; 1993 Jan; 53(1):83-8. PubMed ID: 8380127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative evaluation of preclinical in vivo models for the assessment of replicating retroviral vectors for the treatment of glioblastoma.
    Hlavaty J; Jandl G; Liszt M; Petznek H; König-Schuster M; Sedlak J; Egerbacher M; Weissenberger J; Salmons B; Günzburg WH; Renner M
    J Neurooncol; 2011 Mar; 102(1):59-69. PubMed ID: 20623247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic efficacy of replication-competent retrovirus vector-mediated suicide gene therapy in a multifocal colorectal cancer metastasis model.
    Hiraoka K; Kimura T; Logg CR; Tai CK; Haga K; Lawson GW; Kasahara N
    Cancer Res; 2007 Jun; 67(11):5345-53. PubMed ID: 17545615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Replication-competent retrovirus vector-mediated prodrug activator gene therapy in experimental models of human malignant mesothelioma.
    Kawasaki Y; Tamamoto A; Takagi-Kimura M; Maeyama Y; Yamaoka N; Terada N; Okamura H; Kasahara N; Kubo S
    Cancer Gene Ther; 2011 Aug; 18(8):571-8. PubMed ID: 21660062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VSV-G pseudotyped, MuLV-based, semi-replication-competent retrovirus for cancer treatment.
    Qiao J; Moreno J; Sanchez-Perez L; Kottke T; Thompson J; Caruso M; Diaz RM; Vile R
    Gene Ther; 2006 Oct; 13(20):1457-70. PubMed ID: 16724095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A uniquely stable replication-competent retrovirus vector achieves efficient gene delivery in vitro and in solid tumors.
    Logg CR; Tai CK; Logg A; Anderson WF; Kasahara N
    Hum Gene Ther; 2001 May; 12(8):921-32. PubMed ID: 11387057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction of replication-competent oncolytic retroviral vectors expressing R peptide-truncated 10A1 envelope glycoprotein.
    Lee ES; Jin SY; Kang BK; Jung YT
    J Virol Methods; 2019 Jun; 268():32-36. PubMed ID: 30898575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A retroviral packaging cell line for pseudotype vectors based on glioma-infiltrating progenitor cells.
    Fischer YH; Miletic H; Giroglou T; Litwak S; Stenzel W; Neumann H; von Laer D
    J Gene Med; 2007 May; 9(5):335-44. PubMed ID: 17474071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective radiosensitization of 9L glioma in the brain transduced with double suicide fusion gene.
    Kim JH; Kolozsvary A; Rogulski K; Khil MS; Brown SL; Freytag SO
    Cancer J Sci Am; 1998; 4(6):364-9. PubMed ID: 9853135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delivery of replication-competent retrovirus expressing Escherichia coli purine nucleoside phosphorylase increases the metabolism of the prodrug, fludarabine phosphate and suppresses the growth of bladder tumor xenografts.
    Kikuchi E; Menendez S; Ozu C; Ohori M; Cordon-Cardo C; Logg CR; Kasahara N; Bochner BH
    Cancer Gene Ther; 2007 Mar; 14(3):279-86. PubMed ID: 17218950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase.
    Nanda D; Vogels R; Havenga M; Avezaat CJ; Bout A; Smitt PS
    Cancer Res; 2001 Dec; 61(24):8743-50. PubMed ID: 11751394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenovirus-retrovirus hybrid vectors achieve highly enhanced tumor transduction and antitumor efficacy in vivo.
    Kubo S; Haga K; Tamamoto A; Palmer DJ; Ng P; Okamura H; Kasahara N
    Mol Ther; 2011 Jan; 19(1):76-82. PubMed ID: 20808291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient Prodrug Activator Gene Therapy by Retroviral Replicating Vectors Prolongs Survival in an Immune-Competent Intracerebral Glioma Model.
    Chen SH; Sun JM; Chen BM; Lin SC; Chang HF; Collins S; Chang D; Wu SF; Lu YC; Wang W; Chen TC; Kasahara N; Wang HE; Tai CK
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32093290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced efficiency of prodrug activation therapy by tumor-selective replicating retrovirus vectors armed with the Escherichia coli purine nucleoside phosphorylase gene.
    Tai CK; Wang W; Lai YH; Logg CR; Parker WB; Li YF; Hong JS; Sorscher EJ; Chen TC; Kasahara N
    Cancer Gene Ther; 2010 Sep; 17(9):614-23. PubMed ID: 20467451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vesicular stomatitis virus G pseudotyped retrovector mediates effective in vivo suicide gene delivery in experimental brain cancer.
    Galipeau J; Li H; Paquin A; Sicilia F; Karpati G; Nalbantoglu J
    Cancer Res; 1999 May; 59(10):2384-94. PubMed ID: 10344748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.